Table Of Content

Author index for Volume 126, 2003 Abbott P, see Kapur N, 2693 Bullmore ET, Eimer M, Barker R, Barbeau E, see Joubert S, 2537 Aboul-Enein F, see Lassmann H, 1347 Sahakian BJ, Robbins TW. Inhibition of Barbier A, see Gainotti G, 792 Ada L, Canning CG, Low S-L. Stroke subliminally primed responses _ is Barbieri S, see Foffani G, 2153 patients have selective muscle weakness mediated by the caudate and thalamus: Barker R, see Aron AR, 713 in shortened range. 724 evidence from functional MRI and Barker RA, see Pavese N, 1127 Adams D, see Said G, 376 Huntington's disease. 713 Barnard L, see Foxton JM, 2703 Adeleine P, see Confavreux C, 770 Aronica E, see Geurts JJG, 1755 Barnett SC, see Lakatos A, 598 Adrien KT, see Herbert MR, 1182 Aschenbrenner-Scheibe R, Maiwald T, Baron J-C, see Chételat G, 1955 Agid Y, see Periquet M, 1271 Winterhalder M, Voss HU, Timmer J, Barone P, see Periquet M, 1271 Agid Y, see Pessiglione M, 1392 Schulze-Bonhage A. How well can Bartel P, see Siebert M, 2627 Agosta F, see Rovaris M, 2323 epileptic seizures be predicted? an Bartoccioni E, see Evoli A, 2304 Ahissar M, see Amitay S, E3 (in Part 9) evaluation of a nonlinear method. 2616 Bartolomei F, see Wendling F, 1449 Ahmed Z, see Pryce G, 2191 Ashburner J, see Good CD, 2431 Barton JJ, see Joubert S, 2537 Alexander MP, Stuss DT, Fansabedian N. Atial N, see Bouhassira D, 1068 Barton JJS, see Battelli L, 2164 California Verbal Learning Test: Auburger G, see Riib U, 2257 Bartsch T, Goadsby PJ. Increased responses performance by patients with focal Avnon Y, Nitzan M, Sprecher E, Rogowski in trigeminocervical nociceptive neurons frontal and non-frontal lesions. 1493 Z, Yarnitsky D. Different patterns of to cervical input after stimulation of the Alexander MP, see Stuss DT, 2363 parasympathetic activation in uni- and dura mater. 1801 Almgvist EW, see Squitieri F, 946 bilateral migraineurs. 1660 Bastuji-Garin S, see Guillamo J-S, 152 Alsop D, see Grossman M, 292 Aw ST, see Karlberg M, 956 Bates AT, see Laurens KR. 610 Alter A, see Bar-Or A, 2738 Ayiward EH, see Eckert MA, 482 Bates E, see Saygin AP, 928 Amaro E, see Phillips ML, 669 Aziz Q, see Phillips ML, 669 Batocchi AP, see Evoli A, 2304 Ambrosini A, Rossi P, De Pasqua V, Pierelli Aziz T, see Silberstein P, 2597 Battaglia F, see Quartarone A, 0000 F, Schoenen J. Lack of habituation causes Battelli L, Cavanagh P, Martini P, Barton high intensity dependence of auditory Baas F, see Kwa MSG, 361 JIS. Bilateral deficits of transient visual evoked cortical potentials in migraine. Baba M, see Hattori N, 134 attention in right parietal patients. 2164 2009 Baban D, see Anderson K, 2052 Bauer MPF, see Binder J, 1814 Amitay S, Ben-Yehudah G, Banai K, Bach FW, see Finnerup NB, 57 Bazner H, see Binder J, 1814 Ahissar M. Visual magnocellular deficits Bachoud-Lévi A-C, see Squitieri F, 946 Bechara A, see Bar-On R, 1790 in dyslexia [reply to letter]. E3 (in Part 9) Bagnato F, Jeffries N, Richert ND, Stone Begum T, see Usui K, 632 Andermann F, see Bernasconi A, 2447 RD, Ohayon JM, McFarland HF, Frank Beis J-M, see Le Ber |, 2761 Andermann F, see Bernasconi N, 462 JA. Evolution of T, black holes in patients Bell JE, see Anthony IC, 1058 Anders S, see Lotze M, 866 with multiple sclerosis imaged monthly Bell JE, see Hill AF, 1333 Anderson K, Potter A, Baban D, Davies KE. for 4 years. 1782 Bellance R, see Stevanin G, 1599 Protein expression changes in spinal Bagnato S, see Quartarone A, 2586 Bellanger JJ, see Wendling F, 1449 muscular atrophy revealed with a novel Bakardjiev A, see Herbert MR, 1182 Belliard S, see Piolino P, 2203 antibody array technology. 2052 Baker D, see Pryce G, 2191 Ben-Yehudah G, see Amitay S, E3 Anderson VE, see Singh NA, 2726 Baks T, see Rosso SM, 2016 (in Part 9) Andrew C, see Phillips ML, 669 Balesar R, see Wolswijk G, 1638 Benarroch EE, Schmeichel AM, Low PA, Andrews TC, see Pavese N, 1127 Bamford JM, see Hassan A, 424 Parisi JE. Depletion of ventromedullary Angelov DN, see Gruart A, 115 Banai K, see Amitay S, E3 (in Part 9) NK-I receptor-immunoreactive neurons Anstee D, see Beringue V, 2065 Bannister CM, see Owen-Lynch PJ, 623 in multiple system atrophy. 2183 Antel SB, see Bernasconi A, 2447 Bar-On R, Tranel D, Denburg NL, Bechara Berardelli A, see Gilio F, 1745 Antel SB, see Bernasconi N, 462 A. Exploring the neurological substrate of Bergamaschi B. Glatiramer acetate Anthony IC, Crawford DH, Bell JE. B emotional and social intelligence. 1790 treatment im Devic’s neuromyelitis lymphocytes in the normal brain: Bar-Or A, Nuttall RK, Duddy M, Alter A, optica [letter]. El (in Part 6) contrasts with HIV-associated lymphoid Kim HJ, Ifergan |, Pennington CJ, Bergami A, see Furlan R, 285 infiltrates and lymphomas. 1058 Bourgoin P, Edwards DR, Yong VW. Berger J, see Lassmann H, 1347 Arai K, see Kanai K, 965 Analyses of all matrix metalloproteinase Berger T, see Lassmann H, 1347 Aridon P, see Bonati MT, 1485 members in leukocytes emphasize Berger T, see Wanschitz J, 2034 Arnold DL, see Bernasconi A, 2447 monocytes as major inflammatory Berghoff M, see Kobsar 1, 804 Arnold DL, see Bernasconi N, 462 mediators in multiple sclerosis. 2738 Bergmann C, Zerres K, Senderek J, Rudnik- Aron AR, Schlaghecken F, Fletcher PC, Barbarot S, see Guillamo J-S, 152 Schoneborn S, Eggermann T, Hausler M, © Guarantors of Brain 2778 Index Mull M, Ramaekers VT. Oligophrenin | Bonifati V, see Dekker MCJ, 1722 Budka H, see Wanschitz J, 2034 (OPHN!) gene mutation causes syn- Boongird A, see Yun J, 2667 Buhmann C, Glauche V, Stiirenburg HJ, dromic X-linked mental retardation with Boring D, see Gerwig M, 71 Oechsner M, Weiller C, Biichel C. epilepsy, rostral ventricular enlargement Bosbach S, Kornblum C, Schroder R, Pharmacologically modulated fMRI: and cerebellar hypoplasia. 1537 Wagner M. Executive and visuospatial cortical responsiveness to levodopa in Bergmann C, see Senderek J, 642 deficits in patients with chronic drug-naive hemiparkinsonian patients. Beringue V, Mallinson G, Kaisar M, Tayebi progressive external ophthalmoplegia 451 M, Sattar Z, Jackson G, Anstee D, and Kearns-Sayre syndrome. 1231 Bullens RWM, see Jacobs BC, 2220 Collinge J, Hawke S. _ Regional Boschert U, see Mycko MP, 1048 Bullens RWM, see O'Hanlon GM, 2497 heterogeneity of cellular prion protein Bouhassira D, Danziger N, Attal N, Bullmore E, see Phillips ML, 669 isoforms in the mouse brain. 2065 Guirimand F. Comparison of the pain Bullmore ET, see Aron AR, 713 Berkouk K, see Chételat G, 1955 suppressive effects of clinical and Bullmore ET, see Honey GD, 1767 Berkovic SF, see Marini C, 230 experimental painful conditioning Bullock PR, see Hornak J, 1691 Berkovic SF, see Taylor I, 753 stimuli. 1068 Buonocore G, Perrone S, Longini M, Paffetti Bernasconi A, Bernasconi N, Natsume J, Bourgoin P, see Bar-Or A, 2738 P, Vezzosi P, Gatti MG, Bracci R. Non Antel SB, Andermann F, Arnold DL. Bourien J, see Wendling F, 1449 protein bound iron as early predictive Magnetic resonance spectroscopy and Bozzali M, see Filippi M, 433 marker of neonatal brain damage. 1224 imaging of the thalamus in idiopathic Braak H, see Riib U, 2257 Burbaud P, see Escola L, 95 generalized epilepsy. 2447 Bracci R, see Buonocore G, 1224 Burian M, see Tegeder I, 1092 Bernasconi A, see Bernasconi N, 462 Bradley B, see Kennedy PGE, 1683 Burke D, see Cappelen-Smith C, 1001 Bernasconi N, Bernasconi A, Caramanos Z, Braendgaard H, see Josephs KA, 2291 Burton B, see Kidd D, 276 Antel SB, Andermann F, Arnold DL. Brambilla E, see Furlan R, 285 Busa E, see Sailer M, 1734 Mesial temporal damage in temporal lobe Bramham J, see Hornak J, 1691 Bussey TJ, see Brasted PJ, 1202 epilepsy: a volumetric MRI study of the Brammer M, see Phillips ML, 669 Biitefisch CM, Netz J, Wessling M, Seitz RJ, hippocampus, amygdala and Brand A, see Kwa MSG, 361 Hoémberg V. Remote changes in cortical parahippocampal region. 462 Brandt T, see Jahn K, 1579 excitability after stroke. 470 Bernasconi N, see Bernasconi A, 2447 Brasted PJ, Bussey TJ, Murray EA, Wise Butler IJ, see Jordanova A, 590 Bernert G, see Senderek J, 642 SP. Role of the hippocampal system in Butters TD, see Jeyakumar M, 974 Berninger VW, see Eckert MA, 482 associative learning beyond the spatial The BFNC Physician Consortium, see Singh domain. 1202 Caldara R, see Rossion B, 2381 NA, 2726 Braun C, see Lotze M, 866 Camuzat A, see Stevanin G, 1599 Bhatia KP, see Edwards MJ, 2074 Breteler MMB, see den Heijer T, 170 Cannella M, see Squitieri F, 946 Bhatia KP, see Khan NL, 1279 Brice A, see Le Ber I, 2761 Canning CG, see Ada L, 724 Bhatia KP, see Siebner HR, 2710 Brice A, see Periquet M, 1271 Cappelen-Smith C, Lin CS-Y, Burke D. Bielekova B, see Muraro PA, 20 Brice A, see Stevanin G, 1599 Activity-dependent hyperpolarization and Biering-Sgrensen F, see Crone C, 495 Briley D, see Hassan A, 424 impulse conduction in motor axons in Binder J, Hofmann S, Kreisel S, Wéhrle JC, Brodaty H, see Stanford PM, 814 patients with carpal tunnel syndrome. Biazner H, Krauss JK, Hennerici MG, Broe GA, see Brooks WS, 783 1001 Bauer MF. Clinical and molecular Brol B, see Gerwig M, 71 Caputo E, see Foffani G, 2153 findings in a patient with a novel Brooks DJ, see Goerendt IK, 312 Caramanos Z, see Bernasconi N, 462 mutation in the deafness—dystonia Brooks DJ, see Hammers A, 1300 Carr TD, see Molloy FM, 2175 peptide (DDP1) gene. 1814 Brooks DJ, see Pavese N, 1127 Casari G, see Bonati MT, 1485 Binns MA, see Stuss DT, 2363 Brooks WS, Kwok JBJ, Kril JJ, Broe GA, Casey KL, see Lorenz J, 1079 Bioulac B, see Escola L, 95 Blumbergs PC, Tannenberg AE, Lamont Castellote JM, see Ramus F, 841 Birbaumer N, see Lotze M, 866 PJ, Hedges P, Schofield PR. Alzheimer’s Catani M, Jones DK, Donato R, ffytche DH. Birbaumer N, see Pavlova M, 692 disease with spastic paraparesis and Occipito-temporal connections in the Birk S, see Kruuse C, 241 ‘cotton wool’ plaques: two pedigrees human brain. 2093 Black JA, see Craner MJ, 1552 with PS-1 exon 9 deletions. 783 Cavanagh P, see Battelli L, 2164 Black RA, see Karlberg M, 956 Brooks WS, see Stanford PM, 814 Caviness VS, see Herbert MR, 1182 Blanes W, see Parra J, 1164 Brown CW, see Jordanova A, 590 Ceccaldi M, see Joubert S, 2537 Blumbergs PC, see Brooks WS, 783 Brown J, see Honey GD, 1767 Cerutti S, see Foffani G, 2153 B6 L, see Geurts JJG, 1755 Brown MM, see Hassan A, 424 Ceuterick C, see Jordanova A, 590 Bodammer N, see Sailer M, 1734 Brown MM, see Ward NS, 1430, 2476 Chamayou C, see Le Ber I, 2761 Boerkoel CF, see Jordanova A, 590 Brown P, see Grosse P, 326 Charlier C, see Singh NA, 2726 Boltshauser E, see Steinlin M, 1998 Brown P, see Silberstein P, 2597 Chase B, see Kobayashi H, 32 Bonanni P, see Grosse P, 326 Brown P, see Williams D, 1975 Chase C, Stein J. Visual magnocellular Bonati MT, Ferini-Strambi L, Aridon P, Briick W, see Lassmann H, 1347 deficits in dyslexia [letter]. E2 (in Part 9) Oldani A, Zucconi M, Casari G. Brunt ER, see Riib U, 2257 Chauvel P, see Wendling F, 1449 Autosomal dominant restless legs Biichel C, see Buhmann C, 451 Chen C-C, see Nicot A, 398 syndrome maps on chromosome 14q. Buchfelder M, see Stefan H, 2396 Chen R, see Sailer A, 1883 1485 Budka H, see Hill AF, 1333 Cheng N-C, see Chung M-Y, 1293 Index 2779 Chételat G, Desgranges B, de la Sayette V, Crone C, Johnsen LL, Biering-Serensen F, de Visser M, see Van den Berg-Vos RM, Viader F, Berkouk K, Landeau B, Lalevée Nielsen JB. Appearance of reciprocal 1036 C, Le Doze F, Dupuy B, Hannequin D, facilitation of ankle extensors from de Vos RAI, see Riib U, 2257 Baron J-C, Eustache F. Dissociating ankle flexors in patients with stroke or De Vriendt E, see Jordanova A, 590 atrophy and hypometabolism impact on spinal cord injury. 495 Dekker MCJ,; Bonifati V, van Duijn CM episodic memory in mild cognitive Cross JH, see Devlin AM, 556 Parkinson's disease: piecing together a impairment. 1955 Cross JH, see Scott RC, 1968 genetic jigsaw [review]. 1722 Chevallay M, see Romero NB, 2341 Croxford JL, see Pryce G, 2191 Del Tredici K, see Riib U, 2257 Chiang M-C, see Pan C-L, 386 Cruccu G, Pennisi E, Truini A, lannetti GD, Del Turco D, see Riib U, 2257 Chiron C, see Kaminska A, 248 Romaniello A, Le Pera D, De Armas L, Delalande O, see Kaminska A, 248 Chong WK, see Devlin AM, 556 Leandri M, Manfredi M, Valeriani M. Delatycki M, see Squitieri F, 946 Chumillas MJ, see Sevilla T, 2023 Unmyelinated trigeminal pathways as Delcroix J-D, see Middlemas A, 1671 Chung M-Y, Lu Y-C, Cheng N-C, Soong B- assessed by laser stimuli in humans. 2246 Deleuze J-F, see Periquet M, 1271 W. A_ novel autosomal dominant Crutch SJ, Warrington EK. Spatial coding of Delgado-Garcia JM, see Gruart A, 115 spinocerebellar ataxia (SCA22) linked to semantic information: knowledge of Della Sala S, see Spinazzola L, 2656 chromosome | p21-q23. 1293 country and city names depends on their Dellatolas G, see Kaminska A, 248 Cieuta C, see Kaminska A, 248 geographical proximity. 1821 Demarquay G, see Le Ber I, 2761 Cipolotti L, see Critchley HD, 2139 Cruz RF, see Lausberg H, 343 Demeret S, see Pierrot-Deseilligny C, 1460 Cislaghi G, see Squitieri F, 946 Cubelli R, see Spinazzola L, 2656 den Heijer T, Vermeer SE, Clarke R, Clarke R, see den Heijer T, 170 Cuesta A, see Sevilla T, 2023 Oudkerk M, Koudstaal PJ, Hofman A, Cody FWJ, see Poliakoff E, 2081 Culham J, see James TW, 2463 Breteler MMB. Homocysteine and brain Coen S, see Phillips ML, 669 Cullen S, see Phillips ML, 669 atrophy on MRI of non-demented elderly. Cohen LG, see Lotze M, 866 Curra A, see Gilio F, 1745 170 Collet L, see Hung Thai-Van H, 2235 Cuzner ML, see Gveri¢ D, 1590 Denburg NL, see Bar-On R, 1790 Collinge J, see Beringue V, 2065 Cuzner ML, see Pryce G, 2191 Desgranges B, see Chételat G, 1955 Collinge J, see Hill AF, 1333 Desgranges B, see Piolino P, 2203 Comi G, see Filippi M, 433 Dagher A, see Strafella AP, 2609 Desgranges B, see Quinette P, 1917 Comi G, see Furlan R, 285 Dakin SC, see Ramus F, 841 Detre J, see Grossman M, 292 Comi G, see Rovaris M, 2323 Dale A, see Sailer M, 1734 Deuschl G, see Helmchen C, 1319 Confavreux C, Vukusic S, Adeleine P. Early Damasio AR, see Parvizi J, 1524 Deutsch CK, see Herbert MR, 1182 clinical predictors and progression of Dambrosia JM, see Molloy FM, 2175 DeVita C, see Grossman M, 292 irreversible disability in multiple Danziger N, see Bouhassira D, 1068 Devlin AM, Cross JH, Harkness W, Chong sclerosis: an amnesic process. 770 Danziger N, see Paqueron X, 702 WK, Harding B, Vargha-Khadem F, Connelly A, see Scott RC, 1968, 2551 Daselaar SM, Veltman DJ, Rombouts Neville BGR. Clinical outcomes of Copp AJ, see Lai CSL, 2455 SARB, Raaijmakers JGW, Jonker C. hemispherectomy for epilepsy in Cordivari C, see Siebner HR, 2710 Neuroanatomical correlates of episodic childhood and adolescence. 556 Coriat P, see Paqueron X, 702 encoding and retrieval in young and Dewar B-K, see Critchley HD, 2139 Cortey A, see Romero NB, 2341 elderly subjects. 43 Di Donato S, see Squitieri F, 946 Cosnard G, see Duque J, 732 Dattola V, see Quartarone A, 2586 Di Lazzaro V, see Silberstein P, 2597 Crafton KR, Mark AN, Cramer SC. Davies KE, see Anderson K, 2052 Dichgans J, see Wiend! H, 176 Improved understanding of cortical Davies-Jones A, see Hadjivassiliou M, 685 Dick F, see Saygin AP, 928 injury by incorporating measures of Davis KD, see Hunter JP, 579 Dickson DW, see Josephs KA, 2291 functional anatomy. 1650 Davis M, see Gommans IMP, 1545 Diener HC, see Gerwig M, 71 Cramer SC, see Crafton KR, 1650 Dawson K, see Lambon Ralph MA, 2350 Dieterich M, see Jahn K, 1579 Craner MJ, Lo AC, Black JA, Waxman SG. Day BL, see Ramus F, 841 Dillon J, see Singh NA, 2726 Abnormal sodium channel distribution in d’Azzo A, see Jeyakumar M, 974 DiMauro S, see Taivassalo T, 413 optic nerve axons in a model of De Armas L, see Cruccu G, 2246 Dimitrova A, see Gerwig M, 71 inflammatory demyelination. 1552 De Felipe C, see Kennedy PGE, 1683 Dirks M, see Timmermann L, 199 Crawford DH, see Anthony IC, 1058 de Jong D, see Rosso SM, 2016 Dodeé C, see Stevanin G, 1599 Créange A, see Guillamo J-S, 152 de Jong JMBV, see Van den Berg-Vos RM, Dodel R, see Du Y, 1935 Crinion JT, Lambon-Ralph MA, Warburton 1036 Dolan RJ, see Critchley HD, 2139 EA, Howard D, Wise RJS. Temporal lobe De Jonge RR, see Kwa MSG, 361 Donato R, see Catani M, 2093 regions engaged during normal speech De Jonghe P, see Jordanova A, 590 Dooijes D, see Rosso SM, 2016 comprehension. 1193 De Jonghe P, see Senderek J, 642 Doz F, see Guillamo J-S, 152 Critchley HD, Mathias CJ, Josephs O, de Koning I, see Rosso SM, 2016 Draper CE, see Owen-Lynch PJ, 623 O'Doherty, J, Zanini S, Dewar B-K, de la Sayette V, see Chételat G, 1955 Dressel A, see Hamm AO, 267 Cipolotti L, Shallice T, Dolan RJ. De La Sayette V, see Piolino P, 2203 Dronkers NF, see Saygin AP, 928 Human cingulate cortex and autonomic de la Sayette V, see Quinette P, 1917 Druschky K, see Stefan H, 2396 control: converging neuroimaging and de Leeuw B, see Shams’il i S, 1409 Du Y, Wei X, Dodel R, Sommer N, Hampel clinical evidence. 2139 De Michele G, see Periquet M, 1271 H, Gao F, Ma Z, Zhao L, Oertel WH, Critchley P, see Khan NL, 1279 De Pasqua V, see Ambrosini A, 2009 Farlow M. Human = anti-B-amyloid 2780 Index antibodies block {-amyloid fibril Farlow M, see Du Y, 1935 Freund H-J, see Timmermann L, 199 formation and prevent B-amyloid- Farrow TFD, see Hunter MD, 161 Friston KJ, see Good CD, 2431 induced neurotoxicity. 1935 Féger J, see Pessiglione M, 1392 Friston KJ, see Noppeney U, 1620 Duddy M, see Bar-Or A, 2738 Fehlings MG, see Wells JEA, 1628 Frith CD, see Maguire EA, 1511 Duffy CJ, see Kaveic V, 1173 Felician O, see Joubert S, 2537 Frith U, see Ramus F, 841 Dulac O, see Kaminska A, 248 Fellows LK, Farah MJ. Ventromedial frontal Fritsch B, see Hamer HM, 547 Duncan JS, see Hammers A, 1300 cortex mediates affective shifting in Frot M, Mauguieére F. Dual representation of Dunnett SB, see Pavese N, 1127 humans: evidence from a_ reversal pain in the operculo-insular cortex in Dupont P, see Van Paesschen W, 1103 learning paradigm. 1830 humans. 438 Dupuy B, see Chételat G, 1955 Ferini-Strambi L, see Bonati MT, 1485 Fryer TD, see Nestor PJ, 2406 Duque J, Thonnard J-L, Vandermeeren Y, Fernyhough P, see Middlemas A, 1671 Fuglsang-Frederiksen A, see Finnerup NB, Sébire G, Cosnard G, Olivier E. ffytche DH, see Catani M, 2093 57 Correlation between impaired dexterity Filipovic SR, see Siebner HR, 2710 Fujigasaki H, see Stevanin G, 1599 and corticospinal tract dysgenesis in Filippi M, Bozzali M, Rovaris M, Gonen O, Fujikawa-Brooks S, see Starr A, 1604 congenital hemiplegia. 732 Kesavadas C, Ghezzi A, Martinelli V, Fujiwara T, Sugawara T, Mazaki-Miyazaki Diirr A, see Le Ber I, 2761 Grossman RI, Scotti G, Comi G, Falini A. E, Takahashi Y, Fukushima K, Watanabe Diirr A, see Periquet M, 1271 Evidence for widespread axonal damage M, Hara K, Morikawa T, Yagi K, Durr A, see Stevanin G, 1599 at the earliest clinical stage of multiple Yamakawa K, Inoue Y. Mutations of Dwek RA, see Jeyakumar M, 974 sclerosis. 433 sodium channel @ subunit type | Filippi M, see Rovaris M, 2323 (SCNIA) — in intractable childhood Ebner A, see Janszky J, 2043 Fink GR, see Piefke M, 650 epilepsies with frequent generalized Eckert MA, Leonard CM, Richards TL, Finnerup NB, Johannesen IL, Fuglsang- tonic-clonic seizures. 53] Aylward EH, Thomson J, Berninger VW. Frederiksen A, Bach FW, Jensen TS. Fukudo S, see Kano M, 1474 Anatomical correlates of dyslexia: frontal Sensory function in spinal cord injury Fukushima K, see Fujiwara T, 531 and cerebellar findings. 482 patients with and without central pain. 57 Fukuyama H, see Naito Y, 1562 Edwards DR, see Bar-Or A, 2738 Fischl B, see Sailer M, 1734 Funabiki K, see Naito Y, 1562 Edwards MJ, Huang Y-Z, Wood NW, Fisher SE, see Lai CSL, 2455 Furlan R, Brambilla E, Sanvito F, Rothwell JC, Bhatia KP. Different Fletcher PC, see Aron AR, 713 Roccatagliata L, Olivieri S, Bergami A, patterns of electrophysiological deficits Fletcher PC, see Honey GD, 1767 Pluchino S, Uccelli A, Comi G, Martino in manifesting and non-manifesting Flossmann E, Rothwell PM. Prognosis of G. Vaccination with amyloid-B peptide carriers of the DYT/ gene mutation. 2074 vertebrobasilar transient ischaemic attack induces autoimmune encephalomyelitis in Eggermann T, see Bergmann C, 1537 and minor stroke. 1940 C57/BL6 mice. 285 Egidi M, see Foffani G, 2153 Foffani G, Priori A, Egidi M, Rampini P, Eimer M, see Aron AR, 713 Tamma F, Caputo E, Moxon KA, Gadian DG, see Scott RC, 1968, 2551 El-Mongui A, see Salama HH, 2638 Cerutti S, Barbieri S. 300-Hz Gagnon L, see Hébert S, 1838 Elkabes S, see Nicot A, 398 subthalamic oscillations in Parkinson's Gainottt G, Barbier A, Marra C. Slowly Elliot-Smith E, see Jeyakumar M, 974 disease. 2153 progressive defect in recognition of Escola L, Michelet T, Macia F, Guehl D, Fohlen M, see Kaminska A, 248 familiar people in a patient with right Bioulac B, Burbaud P. Disruption of Fontana A, see Paul R, 1873 anterior temporal atrophy. 792 information processing in the Forsting M, see Gerwig M, 71 Gaivin RJ, see Yun J, 2667 supplementary motor area of the MPTP- Fox NC, see Josephs KA, 229] Gale CR, Walton S, Martyn CN. Foetal and treated monkey: a_ clue to the Foxton JM, Stewart ME, Barnard L, postnatal head growth and risk of pathophysiology of akinesia? 95 Rodgers J, Young AH, O’Brien G, cognitive decline in old age. 2273 Esiri MM, see Medana IM, 515 Griffiths TD. Absence of auditory Ganguly M, see Josephs KA, 2291 European Consortium — on Genetic ‘global interference’ in autism. 2703 Gao F, see Du Y, 1935 Susceptibility in Parkinson’s Disease, Frackowiak RSJ, see Good CD, 2431 Gatti MG, see Buonocore G, 1224 see Periquet M, 1271 Frackowiak RSJ, see Morcom AM, 213 Gaymard B, see Pierrot-Deseilligny C, 1460 Eustache F, see Chételat G, 1955 Frackowiak RSJ, see Siebner HR, 2710 Gee J, see Grossman M, 292 Eustache F, see Piolino P, 2203 Frackowiak RSJ, see Ward NS, 873, 1430. Geisslinger G, see Tegeder 1, 1092 Eustache F, see Quinette P, 1917 2476 Gellera C, see Squitieri F, 946 Evoli A, Tonali PA, Padua L, Lo Monaco M Fraix V, see Periquet M, 127] Genow A, see Stefan H, 2396 , Scuderi F, Batocchi AP, Marino M, Frank JA, see Bagnato F, 1782 Gerrelli D, see Lai CSL, 2455 Bartoccioni E. Clinical correlates with Frank JA, see Stiirzebecher S, 1419 Gerschlager W, see Siebner HR, 2710 anti-MuSK antibodies in generalized Franklin RJM, see Lakatos A, 598 Gerwig M, Dimitrova A, Kolb FP, Maschke seronegative myasthenia gravis. 2304 Franklin RJM, see Penderis J, 1382 M, Brol B, Kunnel A, Boring D, Franssen H, see Van Asseldonk JTH, 186 Thilmann AF, Forsting M, Diener HC, Faist M, see Maurer C, 1146 Franssen H, see Van den Berg-Vos RM, Timmann D. Comparison of eyeblink Falini A, see Filippi M, 433 1036 conditioning in patients with superior Fansabedian N, see Alexander MP, 1493 Fraraccio M, see Strafella AP, 2609 and posterior inferior cerebellar lesions. Farah MJ, see Fellows LK, 1830 French Parkinson’s Disease Genetics Study 71 Fardeau M, see Romero NB, 2341 Group, see Periquet M, 1271 Gettinby G, see Kennedy PGE, 1683 Index 2781 Geurts JJG, Wolswijk G, B6 L, van der Valk Grosse P, Guerrini R, Parmeggiani L, seizures in humans: a study using P, Polman CH, Troost D, Aronica E. Bonanni P, Pogosyan A, Brown P. subdural and depth electrodes. 547 Altered expression patterns of group I and Abnormal corticomuscular and Hamm AO, Weike Al, Schupp HT, Treig T, I] metabotropic glutamate receptors in intermuscular coupling in _ high- Dressel A, Kessler C. Affective multiple sclerosis. 1755 frequency rhythmic myoclonus. 326 blindsight: intact fear conditioning to a Ghezzi A, see Filippi M, 433 Grossman M, Koenig P, Glosser G, DeVita visual cue in a cortically blind patient. Giampietro V, see Phillips ML, 669 C, Moore P, Rhee J, Detre J, Alsop D, Gee 267 Gilio F, Curra A, Inghilleri M, Lorenzano C, J. Neural basis for semantic memory Hammers A, Koepp MJ, Richardson MP, Suppa A, Manfredi M, Berardelli A. difficulty in Alzheimer’s disease: an Hurlemann R, Brooks DJ, Duncan JS. Abnormalities of motor — cortex fMRI study. 292 Grey and white matter flumazenil binding excitability preceding movement in Grossman RI, see Filippi M, 433 in neocortical epilepsy with normal MRI: patients with dystonia. 1745 Gruart A, Streppel M, Guntinas-Lichius O, a PET study of 44 patients. 1300 Gill SS, see Patel NK, 1136 Angelov DN, Neiss WF, Delgado-Garcia Hampel H, see Du Y, 1935 Giovannoni G, see Pryce G, 2191 JM. Motoneuron adaptability to new Handwerker H, see Orstavik K, 567 Girlanda P, see Quartarone A, 2586 motor tasks following two types of Hanemann CO, see Ziichner S, 920 Glauche V, see Buhmann C, 451 facial—facial anastomosis in cats. 115 Hankey DJR, see Pryce G, 2191 Glosser G, see Grossman M, 292 Griinewald R, see Hadjivassiliou M, 685 Hannequin D, see Chételat G, 1955 Goadsby PJ, see Bartsch T, 1801 Griinewald R, see Hadjivassiliou M, ES (in Hara K, see Fujiwara T, 531 Goerendt IK, Messa C, Lawrence AD, Part 9) Harding B, see Devlin AM, 556 Grasby PM, Piccini P, Brooks DJ. Guehl D, see Escola L, 95 Harding B, see Pitt M, 2682 Dopamine release during sequential Guehl D, see Pessiglione M, 1392 Harkin LA, see Marini C, 230 finger movements in health and Guerrini R, see Grosse P, 326 Harkness W, see Devlin AM, 556 Parkinson's disease: a PET study. 312 Guillamo J-S, Créange A, Kalifa C, Grill J, Harris GJ, see Herbert MR, 1182 Gold R, Linington C. Glatiramer acetate Rodriguez D, Doz F, Barbarot S, Zerah Hartung H-P, see Paul R, 1873 treatment in Devic’s neuromyelitis optica M, Sanson M, _ Bastuji-Garin §, Hashimoto N, see Usui K, 632 [reply to letter]. El (in Part 6) Wolkenstein P, Réseau NF France. Hassan A, Hunt BJ, O'Sullivan M, Parmar Gold R, see Schmidt J, 1895 Prognostic factors of CNS tumours in K, Bamford JM, Briley D, Brown MM, Goldman RS, see O’ Hanlon GM, 2497 Neurofibromatosis | (NF1): a Thomas DJ, Markus HS. Markers of Gomez CM, see Maschke M, 2312 retrospective study of 104 patients. 152 endothelial dysfunction in lacunar Gommans IMP, Davis M, Saar K, Lammens Guillery B, see Quinette P, 1917 infarction and ischaemic leukoaraiosis M, Mastaglia F, Lamont P, van Guirimand F, see Bouhassira D, 1068 424 Duijnhoven G, ter Laak HJ, Reis A, Gunraj CA, see Sailer A, 1883 Hattori N, Yamamoto M, Yoshihara T, Vogels OJM, Laing N, van Engelen Guntinas-Lichius O, see Gruart A, 115 Koike H, Nakagawa M, Yoshikawa H, BGM, Kremer H. A locus on Gveri¢ D, Herrera B, Petzold A, Lawrence Ohnishi A, Hayasaka K, Onodera O, Baba chromosome 15q for a dominantly DA, Cuzner ML. Impaired fibrinolysis in M, Yasuda H, Saito T, Nakashima K, Kira inherited nemaline myopathy with core- multiple sclerosis: a role for tissue J, Kaji R, Oka N, Sobue G, Study Group like lesions. 1545 plasminogen activator inhibitors. 1590 for Hereditary Neuropathy in Japan. Gonen O, see Filippi M, 433 Gyoba J, see Kano M, 1474 Demyelinating and axonal features of Gonzalez-Cabrera PJ see Yun J, 2667 Charcot—Marie—Tooth disease with Good CD, Lawrence K, Thomas NS, Price Habert M-O, see Le Ber I, 2761 mutations of myelin-related proteins CJ, Ashburner J, Friston KJ. Frackowiak Hadjivassiliou M, Griinewald R, Sharrack B, (PMP22, MPZ and = Cx32): a RSJ, Oreland L, Skuse DH. Dosage Sanders D, Lobo A, Williamson C, clinicopathological study of 205 sensitive X-linked locus influences the Woodroofe N, Wood N, Davies-Jones A. Japanese patients. 134 development of amygdala and Gluten ataxia in perspective: Hattori N, see Kobayashi H, 32 orbitofrontal cortex, and fear recognition epidemiology, genetic susceptibility and Hattori T, see Kanai K, 965 in humans. 2431 clinical characteristics. 685 Hiusler M, see Bergmann C, 1537 Good CD, see Morcom AM, 213 Hadjivassiliou M, Griinewald R. Gluten Hawke §, see Beringue V, 2065 Goodale MA, see James TW, 2463 ataxia ‘in perspective’ [reply to letter]. Hayasaka K, see Hattori N, 134 Graham E, see Khan NL, 1279 ES (in Part 9) Hayden MR, see Squitieri F, 946 Graham EM, see Kidd D, 276 Hagenow A, see Helmchen C, 1319 Hébert S, Racette A, Gagnon L, Peretz I. Graham N, see Lambon Ralph MA, 2350 Haller RG, see Taivassalo T, 413 Revisiting the dissociation between Graham NL, see Nestor PJ, 2406 Hallett M, see Molloy FM, 2175 singing and speaking in expressive Gran B, see Muraro PA, 20 Halliday GM, see Schofield E, 827 aphasia. 1838 Grasby PM, see Goerendt IK, 312 Halliday GM, see Stanford PM, 814 Hedges P, see Brooks WS, 783 Grefkens J, see Shams’il i S, 1409 Halliday J, see Skladal D, 1905 Hegde N, see Hunter MD, 161 Gregory LJ, see Phillips ML, 669 Halmagyi GM, see Karlberg M, 956 Heide W, see Helmchen C, 1319 Griffiths TD. see Foxton JM, 2703 Halstead SK, see O'Hanlon GM, 2497 Heinemann D, see Janszky J, 2043 Griffiths TD, see Hunter MD, 161 Hamer HM, Liiders HO, Knake S, Fritsch B, Heinze H-J, see Sailer M, 1734 Grill J, see Guillamo J-S, 152 Oertel WH, Rosenow F. Helmchen C, Hagenow A, Miesner J, Grodd W, see Wild B, 2121 Electrophysiology — of focal clonic Sprenger A, Rambold H, Wenzelburger Gross J, see Timmermann L, 199 R, Heide W, Deusch! G. Eye movement 2782 Index abnormalities in essential tremor may Hung Thai-Van H, Micheyl C, Moore BCJ, Milner AD, Goodale MA. Ventral indicate cerebellar dysfunction. 1319 Collet L. Enhanced frequency occipital lesions impair object Hennerici MG, see Binder J, 1814 discrimination near the hearing loss cut- recognition but not object-directed Herbert MR, Ziegler DA, Deutsch CK, off: a consequence of central auditory grasping: an {MRI study. 2463 O’Brien LM, Lange N, Bakardjiev A, plasticity induced by cochlear damage? Janszky J, Jokeit H, Heinemann D, Schulz Hodgson J, Adrien KT, Steele S, Makris 2235 R, Woermann FG, Ebner A. Epileptic N, Kennedy D, Harris GJ, Caviness VS. Hunt BJ, see Hassan A, 424 activity influences the speech Dissociations of cerebral cortex, Hunt SP, see Kennedy PGE, 1683 organization in medial temporal lobe subcortical and cerebral white matter Hunter JP, Katz J, Davis KD. The effect of epilepsy. 2043 volumes in autistic boys. 1182 tactile and visual sensory inputs on Jeannequin C, see Stevanin G, 1599 Herrera B, see Gveri¢ D, 1590 phantom limb awareness. 579 Jeffries N, see Bagnato F, 1782 Heutink P, see Rosso SM, 2016 Hunter MD, Griffiths TD, Farrow TFD, Jellinger K, see Lassmann H, 1347 Heywood P, see Patel NK, 1136 Zheng Y, Wilkinson ID, Hegde N, Woods Jensen TD, see Taivassalo T, 413 Hill AF, Joiner S, Wadsworth JDF, Sidle W, Spence SA, Woodruff PWR. A neural Jensen TS, see Finnerup NB, 57 KCL, Bell JE, Budka H, Ironside JW, basis for the perception of voices in Jeyakumar M, Thomas R, Elliot-Smith E, Collinge J. Molecular classification of external auditory space. 161 Smith DA, van der Spoel AC, d’Azzo A, sporadic Creutzfeldt-Jakob disease. 1333 Hurlbert RJ, see Wells JEA, 1628 Perry VH, Butters TD, Dwek RA, Platt Hilliges M, see Orstavik K, 567 Hurlemann R, see Hammers A, 1300 FM. Central nervous system inflammation Hirano S, see Naito Y, 1562 Husain M, see Mort DJ, 1986 is a hallmark of pathogenesis in mouse Hirata K, see Odaka M, 2279 models of GM1 and GM2 gangliosidosis. Hirsch EC, see Pessiglione M, 1392 lannetti GD, see Cruccu G, 2246 974 Ho AK, see Pavese N, 1127 Ifergan I, see Bar-Or A, 2738 Johannesen IL, see Finnerup NB, 57 Hobson AR, see Phillips ML, 669 Ikeda A, see Usui K, 632 Johnsen LL, see Crone C, 495 Hodges JR, see Lambon Ralph MA, 2350 Imfeid S, see Steinlin M, 1998 Joiner S, see Hill AF, 1333 Hodges JR, see Nestor PJ, 2406 Inghilleri M, see Gilio F, 1745 Jokeit H, see Janszky J, 2043 Hodgson J, see Herbert MR, 1182 Ingle GT, Stevenson VL, Miller DH, Jones DK, see Catani M, 2093 Hofman A, see den Heijer T, 170 Thompson AJ. Primary progressive Jonker C, see Daselaar SM, 43 Hofmann S, see Binder J, 1814 multiple sclerosis: a 5-year clinical and Joosse M, see Rosso SM, 2016 Hofmeister V, see Wiendl H, 176 MR study. 2528 Jordanova A, De Jonghe P, Boerkoel CF, Hohlfeld R, see Wiend! H, 176, 1026 Inglese M, see Rovaris M, 2323 Takashima H, De Vriendt E, Ceuterick C, Hollo A, see Kaminska A, 248 Inoue M, see Naito Y, 1562 Martin J-J, Butler IJ, Mancias P, Holton JL, see Josephs KA, 2291 Inoue Y, see Fujiwara T, 531 Papasozomenos SC, Terespolsky D, Hémberg V, see Biitefisch CM, 470 Insola A, see Silberstein P, 2597 Potocki L, Brown CW, Shy M, Rita DA, Honey GD, Suckling J, Zelaya F, Long C, Iriarte J, see Parra J, 1164 Tournev I, Kremensky I, Lupski JR, Routledge C, Jackson S, Ng V, Fletcher Ironside JW, see Hill AF, 1333 Timmerman V. Mutations in the PC, Williams SCR, Brown J, Bullmore Ishizu K, see Naito Y, 1562 neurofilament light chain gene (NEFL) ET. Dopaminergic drug effects on Ito J, see Naito Y, 1562 cause early onset severe Charcot—Marie- physiological connectivity in a human Itoh M, see Kano M, 1474 Tooth disease. 590 cortico-striato-thalamic system. 1767 Iversen L. Cannabis and the brain [review]. Jorum E, see Orstavik K, 567 Hong J, see Salama HH, 2638 1252 Josephs KA, Holton JL, Rossor MN, Hongo M, see Kano M, 1474 Braendgaard H, Ozawa T, Fox NC, Hooijkaas H, see Shams’il i S, 1409 Jackson G, see Beringue V, 2065 Petersen RC, Pearl GS, Ganguly M, Hopfengirtner R, see Stefan H, 2396 Jackson GD, see Scott RC, 1968 Rosa P, Laursen H, Parisi JE, Waldemar Hornak J, Bramham J, Rolls ET, Morris RG, Jackson S, see Honey GD, 1767 G, Quinn NP, Dickson DW, Revesz T. O'Doherty J, Bullock PR, Polkey CE. Jackson SJ, see Pryce G, 2191 Neurofilament inclusion body disease: a Changes in emotion after circumscribed Jacobs BC, O'Hanlon GM, Bullens RWM, new proteinopathy? 2291 surgical lesions of the orbitofrontal and Veitch J, Plomp JJ, Willison HJ. Josephs O, see Critchley HD, 2139 cingulate cortices. 1691 Immunoglobulins inhibit Joubert S, Felician O, Barbeau E, Hotton G, see Williams D, 1975 pathophysiological effects of anti-GQIb- Sontheimer A, Barton JJ, Ceccaldi M, Houlden H, see Pitt M, 2682 positive sera at motor nerve terminals Poncet M. Impaired configurational Howard D, see Crinion JT, 1193 through inhibition of antibody binding. processing in a case of progressive Hsieh S-T, see Pan C-L, 386 2220 prosopagnosia associated with Huang Y-Z, see Edwards MJ, 2074 Jacobs J, see Pitt M, 2682 predominant right temporal lobe Hudry J, Perrin F, Ryvlin P, Mauguiére F, Jacobson S, see Muraro PA, 20 atrophy. 2537 Royet J-P. Olfactory short-term memory Jahn K, Naess] A, Schneider E, Strupp M, Jurewicz A, Matysiak M, Tybor K, Selmaj and related amygdala recordings in Brandt T, Dieterich M. Inverse U-shaped K. TNF-induced death of adult human patients with temporal lobe epilepsy. curve for age dependency of torsional eye oligodendrocytes is mediated by c-jun 1851 movement responses to galvanic NH,-terminal kinase-3. 1358 Hummel C, see Stefan H, 2396 vestibular stimulation. 1579 Humphrey GK, see James TW, 2463 Jalin C, see Kaminska A, 248 Kaat LD, see Rosso SM, 2016 Humphreys PD, see O’ Hanlon GM, 2497 James TW, Culham J, Humphrey GK, Kaisar M, see Beringue V, 2065 Index 2783 Kaji R, see Hattori N, 134 AE, Wood NW, Lees AJ, Bhatia KP, Kuntzer T, see Le Ber |, 2761 Kalaydjieva L see Kwa MSG, 361 Quinn N. Parkin disease: a phenotypic Kupsch A, see Silberstein P, 2597 Kalifa C, see Guillamo J-S, 152 study of a large case series. 1279 Kupsch A, see Williams D, 1975 Kalitzin SN, see Parra J, 1164 Kidd D, Burton B, Plant GT, Graham EM. Kuwabara S, see Kanai K, 965 Kalmijn S, see Van den Berg-Vos RM, 1036 Chronic relapsing inflammatory optic Kuwabara S, see Odaka M, 2279 Kaltenhauser M, see Stefan H, 2396 neuropathy (CRION). 276 Kwa MSG, van Schaik IN, De Jonge RR, Kamachi M, see Kano M, 1474 Kiehl KA, see Laurens KR, 610 Prand A, Kalaydjieva L, van Belzen N, Kaminska A, Chiron C, Ville D, Dellatolas Kieseier BC, see Paul R, 1873 Vermeulen M, Baas F G, Hollo A, Cieuta C, Jalin C, Delalande Kim CS, see Starr A, 1604 Autoimmunoreactivity to Schwann cells O, Fohlen M, Vera P, Soufflet C, Dulac O. Kim HJ, see Bar-Or A, 2738 in patients with inflammatory Ictal SPECT in children with epilepsy: Kim JS. Pure lateral medullary infarction: neuropathies. 361 comparison with intracranial EEG and clinical—radiological correlation of 130 Kwok JBJ, see Brooks WS, 783 relation to postsurgical outcome. 248 acute, consecutive patients. 1864 Kwok JBJ, see Stanford PM, 814 Kamphorst W, see Rosso SM, 2016 King MD, see Scott RC, 2551 Kanai K, Kuwabara S, Arai K, Sung J-Y, Kira J, see Hattori N, 134 Lacroix C, see Said G, 376 Ogawara K, Hattori T. Muscle cramp in Kita S, see Lausberg H, 343 Lai CSL, Gerrelli D, Monaco AP, Fisher SE, Machado—Joseph disease: altered motor Knake S, see Hamer HM, 547 Copp AJ. FOXP2 expression during brain axonal excitability properties and Kobayashi H, Kriiger R, Markopoulou K, development coincides with adult sites of mexiletine treatment. 965 Wszolek Z, Chase B, Taka H, Mineki R, pathology in a severe speech and Kano M, Fukudo S, Gyoba J, Kamachi M, Murayama K, Riess O, Mizuno Y, Hattori language disorder. 2455 Tagawa M, Mochizuki H, Itoh M, Hongo N. Haploinsufficiency at the @-synuclein Laing N, see Gommans IMP, 1545 M, Yanai K. Specific brain processing of gene underlies phenotypic severity in Lakatos A, Smith PM, Barnett SC, Franklin facial expressions in people’ with familial Parkinson's disease. 32 RJM. Meningeal cells enhance limited alexithymia: an H,'°O-PET study. 1474 Kobsar I, Berghoff M, Samsam M, Wessig CNS remyelination by transplanted Kapur N, Abbott P, Lowman A, Will RG. C, Miurer M, Toyka KV, Martini R. olfactory ensheathing cells. 598 The neuropsychological profile associated Preserved myelin integrity and reduced Lalevée C, see Chetelat G, 1955 with variant Creutzfeldt-Jakob disease. axonopathy in connexin32-deficient mice Lalevée C, see Piolino P, 2203 2693 lacking the recombination activating Lambon Ralph MA, Patterson K, Graham N, Kapur N, Prevett M. Unexpected amnesia: gene-1. 804 Dawson K, Hodges JR. Homogeneity and are there lessons to be learned from cases Koedel U, see Paul R, 1873 heterogeneity in mild cognitive of amnesia following unilateral temporal Koenig M, see Le Ber I, 2761 impairment and Alzheimer’s disease: a lobe surgery? [review]. 2573 Koenig P, see Grossman M, 292 cross-sectional and longitudinal study of Karlberg M, Aw ST, Black RA, Todd MJ, Koepp MJ, see Hammers A, 1300 55 cases. 2350 MacDougall HG, Halmagyi GM. Koga M, see Odaka M, 2279 Lambon-Ralph MA, see Crinion JT, 1193 Vibration-induced ocular torsion and Koike H, see Hattori N, 134 Lammens M, see Gommans IMP, 1545 nystagmus after unilateral vestibular Kolb FP, see Gerwig M, 71 Lamont P, see Gommans IMP, 1545 deafferentation. 956 Konezak J, see Maschke M, 2312 Lamont PJ, see Brooks WS, 783 Kastenbauer S, Pfister H-W. Pneumococcal Kopf M, see Paul R, 1873 Landeau B, see Chetelat G, 1955 meningitis in adults: spectrum of Kornblum C, see Bosbach S, 1231 Landis T, see Vuilleumier P, 889 complications and prognostic factors in a Koudstaal PJ, see den Heijer T, 170 Lang AE, see Sailer A, 1883 series of 87 cases. 1015 Krigeloh-Mann I, see Pavlova M, 692 Lange N, see Herbert MR, 1182 Katz J, see Hunter JP, 579 Krauss JK, see Binder J, 1814 Lassmann H, Reindl! M, Rauschka H, Berger Kaufmann F, see Steinlin M, 1998 Krauss JK, see Silberstein P, 2597 J, Aboul-Enein F, Berger T, Zurbriggen Kaveic V, Duffy CJ. Attentional dynamics Kreisel S, see Binder J, 1814 A, Lutterotti A, Briick W, Weber JR, and visual perception: mechanisms of Kremensky I, see Jordanova A, 590 Ullrich R, Schmidbauer M, Jellinger K, spatial disorientation in Alzheimer’s Kremer H, see Gommans IMP, 1545 Vandevelde M. A new paraclinical CSF disease. 1173 Kremer HP, see Rosso SM, 2016 marker for hypoxia-like tissue damage in Keats B, see Starr A, 1604 Kril JJ, see Brooks WS, 783 multiple sclerosis lesions. 1347 Kennard C, see Mort DJ, 1986 Kril JJ, see Schofield E, 827 Lassmann H, see Wanschitz J, 2034 Kennaway N, see Taivassalo T, 413 Kriiger R, see Kobayashi H, 32 Latouche M, see Periquet M, 1271 Kennedy D, see Herbert MR, 1182 Kruuse C, Thomsen LL, Birk S, Olesen J. Laurens KR, Ngan ETC, Bates AT, Kiehl Kennedy PGE, Rodgers J, Bradley B, Hunt Migraine can be induced by sildenafil KA, Liddle PF. Rostral anterior cingulate SP, Gettinby G, Leeman SE, De Felipe C, without changes in middle cerebral artery cortex dysfunction during — error Murray M. Clinical and diameter. 241 processing in schizophrenia. 610 neuroinflammatory responses to Kiihn A, see Williams D, 1975 Laursen H, see Josephs KA, 2291 meningoencephalitis in substance P Kiihn AA, see Silberstein P, 2597 Lausberg H, Cruz RF, Kita S, Zaidel E, Ptito receptor knockout mice. 1683 Kumar A, Mann §S, Sossi V, Ruth TJ, Stoess! A. Pantomime to visual presentation of Kersaitis C, see Schofield E, 827 AJ, Schulzer M, Lee CS. [''C)]DTBZ-PET objects: left hand dyspraxia in patients Kesavadas C, see Filippi M, 433 correlates of levodopa responses in with complete callosotomy. 343 Kessler C, see Hamm AO, 267 asymmetric Parkinson's disease. 2648 Lawrence AD, see Goerendt IK, 312 Khan NL, Graham E, Critchley P, Schrag Kunnel A, see Gerwig M, 71 Lawrence DA, see Gveri¢ D, 1590 2784 Index Lawrence K, see Good CD, 2431 Lutterotti A, see Lassmann H, 1347 Mathias CJ, see Critchley HD, 2139 Lazeyras F, see Rossion B, 2381 Matsuhashi M, see Usui K, 632 Le Ber I, Moreira M-C, Rivaud-Péchoux S, Ma Z, see Du Y, 1935 Mattar P, see Stiirzebecher S, 1419 Chamayou C, Ochsner F, Kuntzer T, McCarter R, see Patel NK, 1136 Matthews PM, see Parry AMM, 2750 Tardieu M, Said G, Habert M-O, McCune DF, see Yun J, 2667 Matuszewski V, see Piolino P, 2203 Demarquay G, Tannier C, Beis J-M, MacDougall HG, see Karlberg M, 956 Matysiak M, see Jurewicz A, 1358 Brice A, Koenig M, Diirr A. Cerebellar McFarland HF, see Bagnato F, 1782 Mauguiére F, see Frot M, 438 ataxia with oculomotor apraxia type |: McFarland HF, see Muraro PA, 20 Mauguiere F, see Hudry J, 1851 clinical and genetic studies. 2761 McFarland HF, see Stiirzebecher S, 1419 Maurer C, Mergner T, Xie J, Faist M, Pollak Le Doze F, see Chételat G, 1955 McGlone FP, see Poliakoff E, 2081 P, Liicking CH. Effect of chronic bilateral Le Pera D, see Cruccu G, 2246 Macia F, see Escola L, 95 subthalamic nucleus (STN) stimulation Leandri M, see Cruccu G, 2246 Maes A, see Van Paesschen W, 1103 on postural control in Parkinson’s disease. Lebre A-S, see Stevanin G, 1599 Maglione V, see Squitieri F, 946 1146 Ledent C, see Pryce G, 2191 Maguire EA, Frith CD. Aging affects the Maurer M, see Kobsar I, 804 Lee CS, see Kumar A, 2648 engagement of the hippocampus during Mayer E, see Rossion B, 2381 Leeman SE, see Kennedy PGE, 1683 autobiographical memory retrieval. 1511 Mayordomo F, see Sevilla T, 2023 Lees AJ, see Khan NL, 1279 Maier H, see Wanschitz J, 2034 Mazaki-Miyazaki E, see Fujiwara T, 531 Leguen M, see Paqueron X, 702 Maiwald T, see Aschenbrenner-Scheibe R, Mazevet D, Meunier S, Pradat-Diehl P, Leonard CM, see Eckert MA, 482 2616 Marchand-Pauvert V, Pierrot-Deseilligny Leppert MF, see Singh NA, 2726 Makowski A, see Senderek J, 642 E. Changes in propriospinally mediated Leroy JP, see Romero NB, 2341 Makris N, see Herbert MR, 1182 excitation of upper limb motoneurons in Leslie J, see Singh NA, 2726 Malhotra P, see Mort DJ, 1986 stroke patients. 988 Liddle PF, see Laurens KR, 610 Mallinson G, see Beringue V, 2065 Mazzone P, see Silberstein P, 2597 Lidsky TI, Schneider JS. Lead neurotoxicity Mancias P, see Jordanova A, 590 Medana IM, Esiri MM. Axonal damage: a in children: basic mechanisms and Manfredi M, see Cruccu G, 2246 key predictor of outcome in human CNS clinical correlates [review]. 5 Manfredi M, see Gilio F, 1745 diseases [review]. 515 Lin CS-Y, see Cappelen-Smith C, 1001 Mann S, see Kumar A, 2648 Meier S, see Tegeder I, 1092 Lin W-M, see Pan C-L, 386 Mannan SK, see Mort DJ, 1986 Melms A, see Wiendl H, 176, 1026 Lin Y-H, see Pan C-L, 386 Marchand-Pauvert V. see Mazevet D, 988 Mergner T, see Maurer C, 1146 Linington C, see Gold R, El (in Part 6) Marini C, Harkin LA, Wallace RH, Mulley Messa C, see Goerendt IK, 312 Linthicum F, see Starr A, 1604 JC, Scheffer IE, Berkovic SF. Childhood Metselaar JM, see Schmidt J, 1895 Lo AC, see Craner MJ, 1552 absence epilepsy and febrile seizures: a Meunier S, see Mazevet D, 988 Lo Monaco M , see Evoli A, 2304 family with a GABA, receptor mutation. Michalewski HJ, see Starr A, 1604 Lobo A, see Hadjivassiliou M, 685 230 Michelet T, see Escola L, 95 Lochmuller H, see Wiendl H, 176, 1026 Marino M, see Evoli A, 2304 Micheyl C, see Hung Thai-Van H, 2235 Lohmann E, see Periquet M, 1271 Mariotti C, see Squitieri F, 946 Middlemas A, Delcroix J-D, Sayers NM, Long C, see Honey GD, 1767 Mark AN, see Crafton KR, 1650 Tomlinson DR, Fernyhough P. Enhanced Longini M, see Buonocore G, 1224 Markopoulou K, see Kobayashi H, 32 activation of axonally transported stress- Lopes da Silva FH, see Parra J, 1164 Markowitsch HJ, see Piefke M, 650 activated protein kinases in peripheral Lorenz J, Minoshima S, Casey KL. Keeping Markowitsch HJ, see Siebert M, 2627 nerve in diabetic neuropathy is prevented pain out of mind: the role of the Markus HS, see Hassan A, 424 by neurotrophin-3. 1671 dorsolateral prefrontal cortex in pain Marques A, see Muraro PA, 20 Miesner J, see Helmchen C, 1319 modulation. 1079 Marra C, see Gainotti G, 792 Mikuni N, see Usui K, 632 Lorenzano C, see Gilio F, 1745 Martens E, see Nelissen I, 1371 Miller DH, see Ingle GT, 2528 Létsch J, see Tegeder I, 1092 Martin J-J, see Jordanova A, 590 Mills KR. The natural history of central Lotze M, Braun C, Birbaumer N, Anders S, Martin R, see Muraro PA, 20 motor abnormalities in amyotrophic Cohen LG. Motor learning elicited by Martin R, see Stiirzebecher S, 1419 lateral sclerosis. 2558 voluntary drive. 866 Martinelli M, see Rovaris M, 2323 Milner AD, see James TW, 2463 Lévblad K-O, see Steinlin M, 1998 Martinelli V, see Filippi M, 433 Mineki R, see Kobayashi H, 32 Love S, see Patel NK, 1136 Martini P, see Battelli L, 2164 Minoshima S, see Lorenz J, 1079 Low PA, see Benarroch EE, 2183 Martini R, see Kobsar I, 804 Mitsdoerffer M, see Wiendl H, 176, 1026 Low S-L, see Ada L, 724 Martino G, see Furlan R, 285 Miyamoto S, see Usui K, 632 Lowman A, see Kapur N, 2693 Martins RN, see Stanford PM, 814 Miyan JA, see Owen-Lynch PJ, 623 Lozeron P, see Said G, 376 Martyn CN, see Gale CR, 2273 Mizuno Y, see Kobayashi H, 32 Lu Y-C, see Chung M-Y, 1293 Maschke M, Gomez CM, Tuite PJ, Konczak Mochizuki H, see Kano M, 1474 Lucchelli F, see Papagno C, 2419 J. Dysfunction of the basal ganglia, but Mohr C, see Vuilleumier P, 889 Liicking CH, see Maurer C, 1146 not the cerebellum, impairs kinaesthesia. Mok Q, see Pitt M, 2682 Liiders HO, see Hamer HM, 547 2312 Molloy FM, Carr TD, Zeuner KE, Lunardi J, see Romero NB, 2341 Maschke M, see Gerwig M, 71 Dambrosia JM, Hallett M. Abnormalities Lupski JR, see Jordanova A. 590 Mashayekhi F, see Owen-Lynch PJ, 623 of spatial discrimination in focal and Liithy AR, see Steinlin M, 1998 Mastaglia F, see Gommans IMP, 1545 generalized dystonia. 2175 Index 2785 Molnar GF, see Sailer A, 1883 Netz J, see Biitefisch CM, 470 O'Sullivan M, see Hassan A, 424 Monaco AP, see Lai CSL, 2455 Neville BGR, see Devlin AM, 556 Oudkerk M, see den Heijer T, 170 Monnier N, see Romero NB, 2341 Neville BGR, see Scott RC, 1968, 2551 Owen-Lynch PJ, Draper CE, Mashayekhi F, Moore AP, see Poliakoff E, 2081 Ng V, see Honey GD, 1767 Bannister CM, Miyan JA. Defective cell Moore BCJ, see Hung Thai-Van H, 2235 Ng V, see Phillips ML, 669 cycle control underlies abnormal cortical Moore P, see Grossman M, 292 Ngan ETC, see Laurens KR, 610 development in the hydrocephalic Texas Morcom AM, Good CD, Frackowiak RSJ, Nicholl D, see Periquet M, 1271 rat. 623 Rugg MD. Age effects on the neural Nicot A, Ratnakar PV, Ron Y, Chen C-C, Ozawa T, see Josephs KA, 2291 correlates of successful memory Elkabes S. Regulation of gene expression encoding. 213 in experimental autoimmune Padua L, see Evoli A, 2304 Moreira M-C, see Le Ber I, 2761 encephalomyelitis indicates early Paffetti P, see Buonocore G, 1224 Morgante F, see Quartarone A, 2586 neuronal dysfunction. 398 Palace J, see Parry AMM, 2750 Morikawa T, see Fujiwara T, 531 Nielsen JB, see Crone C, 495 Palau F, see Sevilla T, 2023 Morris RG, see Hornak J, 1691 Niermeijer MF, see Rosso SM, 2016 Pambakian A, see Mort DJ, 1986 Mort DJ, Maihotra P, Mannan SK, Rorden Nitzan M, see Avnon Y, 1660 Pan C-L, Tseng T-J, Lin Y-H, Chiang M-C, C, Pambakian A, Kennard C, Husain M. Noppeney U, Friston KJ, Price CJ. Effects of Lin W-M, Hsieh S-T. Cutaneous The anatomy of visual neglect. 1986 visual deprivation on the organization of innervation in Guillain-Barré syndrome: Moxon KA, see Foffani G, 2153 the semantic system. 1620 pathology and clinical correlations. Muggia S, see Papagno C, 2419 Nuttall RK, see Bar-Or A, 2738 386 Mull M, see Bergmann C, 1537 Papagno C, Lucchelli F, Muggia S, Rizzo S. Mulley JC, see Marini C, 230 O’Boyle DJ, see Poliakoff E, 2081 Idiom comprehension in Alzheimer’s Muraro PA, Wandinger K-P, Bielekova B, O'Brien G, see Foxton JM, 2703 disease: the role of the central executive. Gran B, Marques A, Utz U, McFarland O’Brien LM, see Herbert MR, 1182 2419 HF, Jacobson S, Martin R. Molecular Ochsner F, see Le Ber I, 2761 Papasozomenos SC, see Jordanova A, 590 tracking of antigen-specific T cell clones Odaka M, Yuki N, Yamada M, Koga M, Papay RS, see Yun J, 2667 in neurological immune-mediated Takemi T, Hirata K, Kuwabara S. Papoian R, see Mycko MP, 1048 disorders. 20 Bickerstaff's brainstem encephalitis: Pappas C, see Singh NA, 2726 Murayama K, see Kobayashi H, 32 clinical features of 62 cases and a Paqueron X, Leguen M, Rosenthal D, Coriat Miiri RM, see Pierrot-Deseilligny C, 1460 subgroup associated with Guillain-Barré P, Willer JC, Danziger N. The Murphy KJ, see Stuss DT, 2363 syndrome. 2279 phenomenology of body image Murray EA, see Brasted PJ, 1202 O'Doherty J, see Hornak J, 1691 distortions induced by regional Murray M, see Kennedy PGE, 1683 O'Doherty J, see Critchley HD, 2139 anaesthesia. 702 Mycko MP, Papoian R, Boschert U, Raine Oechsner M, see Buhmann C, 451 Paradiso G, see Sailer A, i883 CS, Selmaj KW. cDNA _ microarray Oertel WH, see Du Y, 1935 Parisi JE, see Benarroch EE, 2183 analysis in multiple sclerosis lesions: Oertel WH, see Hamer HM, 547 Parisi JE, see Josephs KA, 2291 detection of genes associated with Ogawara K, see Kanai K, 965 Parmar K, see Hassan A, 424 disease activity. 1048 O’Hanlon GM, Humphreys PD, Goldman Parmeggiani L, see Grosse P, 326 RS, Halstead SK, Bullens RWM, Plomp Parra J, Kalitzin SN, Inarte J, Blanes W, Naessl A, see Jahn K, 1579 JJ, Ushkaryov Y, Willison HJ. Calpain Velis DN, Lopes da Silva FH. Gamma- Nagahama Y, see Naito Y, 1562 inhibitors protect against axonal band phase clustering and Naito Y, Tateya I, Hirano S, Inoue M, degeneration in a model of anti- photosensitivity: is there an underlying Funabiki K, Toyoda H, Ueno M, Ishizu K, ganglioside antibody-mediated motor mechanism common to photosensitive Nagahama Y, Fukuyama H, Ito J. Cortical nerve terminal injury. 2497 epilepsy and visual perception? 1164 correlates of vestibulo-ocular reflex O'Hanlon GM, see Jacobs BC, 2220 Parry AMM, Scott RB, Palace J, Smith S§, modulation: a PET study. 1562 Ohayon JM, see Bagnato F, 1782 Matthews PM. Potentially adaptive Najm I, see Yun J, 2667 Ohnishi A, see Hattori N, 134 functional changes in cognitive Nakagawa M, see Hattori N, 134 Oka N, see Hattori N, 134 processing for patients with multiple Nakashima K, see Hattori N, 134 Oldani A, see Bonati MT, 1485 sclerosis and their acute modulation by Natsume J, see Bernasconi A, 2447 Olesen J, see Kruuse C, 241 rivastigmine. 2750 Neiss WF, see Gruart A, 115 Olivier E, see Duque J, 732 Parvizi J, Damasio AR. Neuroanatomical Nelis E, see Senderek J, 642 Olivieri S, see Furlan R, 285 correlates of brainstem coma. 1524 Nelissen I, Martens E, Van Den Steen PE, Oliviero A, see Silberstein P, 2597 Patel NK, Heywood P, O'Sullivan K, Proost P, Ronsse I, Opdenakker G. Onodera O, see Hattori N, 134 McCarter R, Love S, Gill SS. Unilateral Gelatinase B/matrix metalloproteinase-9 Opdenakker G, see Nelissen I, 1371 subthalamotomy in the treatment of cleaves interferon-B and is a target for Oreland L, see Good CD, 2431 Parkinson's disease. 1136 immunotherapy. 1371 Orstavik K, Weidner C, Schmidt R, Schmelz Patterson K, see Lambon Ralph MA, 2350 Nestor PJ, Graham NL, Fryer TD, Williams M, Hilliges M, Jorum E, Handwerker H, Patterson K, see Nestor PJ, 2406 GB, Patterson K, Hodges JR. Progressive Torebjérk E. Pathological C-fibres in Paul R, Koedel U, Winkler F, Kieseier BC, non-fluent aphasia is associated with patients with a chronic painful condition. Fontana A, Kopf M, Hartung H-P, Pfister hypometabolism centred on the left 567 H-W. Lack of IL-6 = augments anterior insula. 2406 O'Sullivan K, see Patel NK, 1136 inflammatory response but decreases 2786 Index vascular permeability in __ bacterial Piccini P, see Pavese N, 1127 meningitis. 1873 Piefke M, Weiss PH, Zilles K, Markowitsch Quartarone A, Bagnato S, Rizzo V, Siebner Paus T, see Strafella AP, 2609 HJ, Fink GR. Differential remoteness and HR, Dattola V, Scalfari A, Morgante F, Pavese N, Andrews TC, Brooks DJ, Ho AK, emotional tone modulate the neural Battaglia F, Romano M, Girlanda P. Rosser AE, Barker RA, Robbins TW, correlates of autobiographical memory. Abnormal associative plasticity of the Sahakian BJ, Dunnett SB, Piccini P. 650 human motor cortex in writer's cramp. Progressive striatal and _ cortical Pierelli F, see Ambrosini A, 2009 2586 dopamine receptor dysfunction in Pierrot-Deseilligny C, Miiri RM, Ploner CJ, Quinette P, Guillery B, Desgranges B, de la Huntington's disease: a PET study. 1127 Gaymard B, Demeret S, Rivaud-Pechoux Sayette V, Viader F, Eustache F. Working Pavlova M, Staudt M, Sokolov A, S. Decisional role of the dorsolateral memory and executive functions in Birbaumer N, Krageloh-Mann I. prefrontal cortex in ocular motor transient global amnesia. 1917 Perception and production of biological behaviour. 1460 Quinn N, see Khan NL, 1279 movement in patients with early Pierrot-Deseilligny E, see Mazevet D, 988 Quinn NP, see Josephs KA, 2291 periventricular brain lesions. 692 Pijnenburg Y, see Rosso SM, 2016 Pearl GS, see Josephs KA, 2291 Piolino P, Desgranges B, Belliard S, Raaijmakers JGW, see Daselaar SM, 43 Pedrola L, see Sevilla T, 2023 Matuszewski V, Lalevée C, De La Racette A, see Hébert S, 1838 Penderis J, Shields SA, Franklin RJM. Sayette V, Eustache F. Autobiographical Raine CS, see Mycko MP, 1048 Impaired remyelination and depletion of memory and autonoetic consciousness: Ramaekers VT, see Bergmann C, 1537 oligodendrocyte progenitors does not triple dissociation in neurodegenerative Ramaekers VT, see Senderek J, 642 occur following repeated episodes of diseases. 2203 Rambold H, see Helmchen C, 1319 focal demyelination in the rat central Pitt M, Houlden H, Jacobs J, Mok Q, Rampini P, see Foffani G, 2153 nervous system. 1382 Harding B, Reilly M, Surtees R. Severe Ramus F, Rosen S, Dakin SC, Day BL, Pennington CJ, see Bar-Or A, 2738 infantile neuropathy with diaphragmatic Castellote JM, White S, Frith U. Theories Pennisi E, see Cruccu G, 2246 weakness and its relationship to of developmental dyslexia: insights from Peretz I, see Hébert S, 1838 SMARD1. 2682 a multiple case study of dyslexic adults. Perez DM, see Yun J, 2667 Plant GT, see Kidd D, 276 841 Periquet M, Latouche M, Lohmann E, Planté V, see Said G, 376 Raskin S, see Periquet M, 1271 Rawal N, De Michele G, Ricard §S, Platt FM, see Jeyakumar M, 974 Ratnakar PV, see Nicot A, 398 Teive H, Fraix V, Vidailhet M, Nicholl Plomp JJ, see Jacobs BC, 2220 Rauschka H, see Lassmann H, 1347 D, Barone P, Wood NW, Raskin S, Plomp JJ, see O° Hanlon GM, 2497 Ravid R, see Rosso SM, 2016 Deleuze J-F, Agid Y, Diirr A, Brice A, Ploner CJ, see Pierrot-Deseilligny C, 1460 Rawal N, see Periquet M, 1271 French Parkinson’s Disease Genetics Pluchino S, see Furlan R, 285 Reifenberger G, see Riib U, 2257 Study Group, European Consortium on Pocock JM, see Pryce G, 2191 Reilly M, see Pitt M, 2682 Genetic Susceptibility in Parkinson's Pogosyan A, see Grosse P, 326 Reindl M, see Lassmann H, 1347 Disease. Parkin mutations are frequent Poliakoff E, O’Boyle DJ, Moore AP, Reis A, see Gommans IMP, 1545 in patients with isolated early-onset McGlone FP, Cody FWJ, Spence C. Reisman DS, Scholz JP. Aspects of joint parkinsonism. 1271 Orienting of attention and Parkinson's coordination are preserved during Perrig W, see Steinlin M, 1998 disease: tactile inhibition of return and pointing in persons with post-stroke Perrin F, see Hudry J, 1851 response inhibition. 2081 hemiparesis. 2510 Perrone S, see Buonocore G, 1224 Polkey CE, see Hornak J, 1691 Réseau NF France, see Guillamo J-S, 152 Perry VH, see Jeyakumar M, 974 Pollak P, see Maurer C, 1146 Revesz T, see Josephs KA, 2291 Pessiglione M, Guehl D, Agid Y, Hirsch EC, Polman CH, see Geurts JJG, 1755 Rhee J, see Grossman M, 292 Féger J, Tremblay L. Impairment of Poncet M, see Joubert S, 2537 Ricard S, see Periquet M, 1271 context-adapted movement selection in a Potocki L, see Jordanova A, 590 Richards TL, see Eckert MA, 482 primate model of presymptomatic Potter A, see Anderson K, 2052 Richardson MP, see Hammers A, 1300 Parkinson’s disease. 1392 Pradat-Diehl P, see Mazevet D, 988 Richert ND, see Bagnato F, 1782 Petersen RC, see Josephs KA, 2291 Prevett M, see Kapur N, 2573 Riess O, see Kobayashi H, 32 Petrides M, see Thaiss L, 1112 Price CJ, see Good CD, 2431 Rita DA, see Jordanova A, 590 Petzold A, see Gverié D, 1590 Price CJ, see Noppeney U, 1620 Rivaud-Péchoux S, see Le Ber I, 2761 Petzold A, see Pryce G, 2191 Priftis K, Rusconi E, Umilta C, Zorzi M. Rivaud-Pechoux S, see Pierrot-Deseilligny Pfister H-W, see Kastenbauer S, 1015 Pure agnosia for mirror stimuli after right C, 1460 Pfister H-W, see Paul R, 1873 inferior parietal lesion. 908 Rizzo S, see Papagno C, 2419 Phillips ML, Gregory LJ, Cullen S, Coen S, Priori A, see Foffani G, 2153 Rizzo V, see Quartarone A, 2586 Ng V, Andrew C, Giampietro V, Proost P, see Nelissen I, 1371 Robbins TW, see Aron AR, 713 Bullmore E, Zelaya F, Amaro E, Pryce G, Ahmed Z, Hankey DJR, Jackson Robbins TW, see Pavese N, 1127 Thompson DG, Hobson AR, Williams SJ, Croxford JL, Pocock JM, Ledent C, Roccatagliata L, see Furlan R, 285 SCR, Brammer M, Aziz Q. The effect of Petzold A, Thompson AJ, Giovannoni G, Rodden FA, see Wild B, 2121 negative emotional context on neural and Cuzner ML, Baker D. Cannabinoids Rodgers J, see Foxton JM, 2703 behavioural responses to oesophageal inhibit neurodegeneration in models of Rodgers J, see Kennedy PGE, 1683 stimulation. 669 multiple sclerosis. 2191 Rodriguez D, see Guillamo J-S, 152 Piccini P, see Goerendt IK, 312 Ptito A, see Lausberg H, 343 Rogowski Z, see Avnon Y, 1660